[Sublingual clonidine in hypertensive crises]. 1987

O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000286 Administration, Sublingual Administration of a soluble dosage form by placement under the tongue. Drug Administration, Sublingual,Sublingual Drug Administration,Sublingual Administration,Administration, Sublingual Drug,Administrations, Sublingual,Administrations, Sublingual Drug,Drug Administrations, Sublingual,Sublingual Administrations,Sublingual Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
January 1981, Bollettino della Societa italiana di cardiologia,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
September 1992, Recenti progressi in medicina,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
February 1988, Medicina clinica,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
June 1988, Medicina clinica,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
September 1985, Lancet (London, England),
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
April 1986, Medicina clinica,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
September 1994, Investigacion clinica,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
July 1988, Journal of clinical pharmacology,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
January 1987, Archives of internal medicine,
O Muñiz Grijalvo, and J Lapetra Peralta, and J Villar Ortiz, and M A González de la Puente
May 1974, The Medical journal of Australia,
Copied contents to your clipboard!